metabolic disease

Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.

With some out-of-the-box engineering, researchers have developed a nature-inspired strategy to turn sugar in packaged foods into gut-healthy fiber.

Mitchell Lazar studies the transcription factors linking circadian disruption to obesity and diabetes.

Researchers investigated the liquid surrounding the cashew nut as a possible new treatment source for metabolic diseases such as diabetes.

By using extracellular vesicles to target specific neurons in the hypothalamus, scientists induced weight loss in a mouse model of obesity without altering its diet or exercise.

University of Arizona researcher looks beyond traditional causes to find novel therapies